Background: Venous access devices commonly used in clinical practice for long-term chemotherapy of breast cancer include central venous catheters (CVCs), peripherally inserted central venous catheters (PICCs), and implantable venous access ports (IVAPs). CVCs and PICCs are less costly to place but have a higher complication rate than IVAPs. However, there is a lack of cost-utility comparisons among the three devices. The aim of this study was to assess the cost-effectiveness of three catheters for long-term chemotherapy in breast cancer patients. Methods: This study used propensity score matching (PSM) to establish a retrospective cohort. Decision tree models were used to compare the cost-effectiveness of three different intravenous lines in breast cancer chemotherapy patients. Cost parameters were derived from data extracted from the outpatient and inpatient charging systems, and total costs included costs of placement, maintenance, extraction, and handling of complications; utility parameters were derived from previous cross-sectional survey results of the research group; and complication rates were derived from breast cancer catheterization patient information as well as follow-up information. Quality-adjusted life years (QALYs) were measured for efficacy outcomes. Incremental cost-effectiveness ratios (ICERs) were used to compare the three strategies. To assess uncertainty in model parameters, sensitivity analyses (univariate sensitivity analysis and probabilistic sensitivity analysis) were performed. Results: A total of 10,718 patients (3780 after propensity score matching) were included. IVAPs had the smallest cost-utility ratio, and PICCs had the largest cost-utility ratio when left in place for more than 12 months. The incremental cost-utility ratio of PICC to CVC was $2375.08/QALY, IVAP to PICC was $522.01/QALY, and IVAP to CVC was $612.98/QALY. Incremental cost-effectiveness ratios showed that IVAPs were more effective than CVCs and PICCs. Model regression analysis showed that the IVAP was recommended as the best regimen regardless of the catheter indwelling time (6 months, 12 months or more than 12 months). The reliability and stability of the model were verified by single-factor sensitivity analysis and Monte Carlo simulation (probabilistic sensitivity analysis). Conclusion: This study provides economic evidence for the selection of vascular access in breast cancer chemotherapy patients. In the case of limited resources in China, establishing a decision tree model comparing the cost-effectiveness of three vascular access devices for breast cancer chemotherapy patients determined that the IVAP was the most cost-effective regimen.
Cervical cancer is a global health challenge for women, characterized by high morbidity and mortality rates, along with long-term health consequences and economic burden. Early screening and timely treatment can effectively manage cervical cancer, making it crucial for patients to seek medical attention promptly. Positive health-seeking behaviors (HSB) involve the awareness of health issues, self-assessment of health status, and the proactive gathering of information and taking appropriate actions to maintain health. Positive HSB are key to reducing the risk of delayed healthcare access for cervical cancer patients. However, delays in seeking medical care remain prevalent globally. This study aimed to explore the underlying factors contributing to delayed medical care in cervical cancer patients. The findings provide a basis for improving the timely access to care for these patients. The study was conducted between July 2024 and October 2024 at a tertiary oncology hospital in China. Cervical cancer patients who experienced delays in seeking medical care were purposively sampled and interviewed. Health-seeking behaviours were collected through semi-structured interviews. Data were analyzed using a theory-driven thematic approach, guided by the Health Belief Model (HBM). Seventeen cervical cancer patients participated in the study. Four themes emerged: (1) perception and assessment of symptoms (lack of knowledge, benign attribution of symptoms, ignorance of symptoms); (2) perceived threat of the disease (feeling healthy, low susceptibility, no symptomatic threat); (3) perceived benefits and barriers to health-seeking behaviours (reduced disease threat, alleviated psychological and financial burden, low awareness of healthcare access, health insurance coverage, limited healthcare resources); and (4) cues to action (family support, symptom exacerbation). In general, patients with cervical cancer who lack knowledge about the disease and have a diminished perception of the threat of the disease may or may not choose to seek timely medical care after assessing the benefits of health-seeking behaviours and the barriers they face. This study identifies key barriers to health-seeking behaviours among cervical cancer patients, including limited awareness of early symptoms and underestimated perceptions of risk and severity. It suggests that future interventions should adopt a multifaceted approach targeting healthcare providers, patients, and their social support systems. This strategy should emphasize disease-related knowledge and timely health-seeking behaviours. Clinically, greater emphasis on culturally sensitive communication and patient education is needed to reduce stigma and fear associated with gynecological care. At the policy level, expanding access to affordable screening services and strengthening rural healthcare infrastructure could help reduce disparities and promote earlier diagnosis and treatment.